Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2022) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Rheumatology. ISSN 1462-0324

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2022, Oxford University Press. This is an author produced version of an article published in Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 7 July 2022
  • Accepted: 20 June 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Aug 2022 15:01
Last Modified: 07 Jul 2023 00:13
Status: Published online
Publisher: Oxford University Press (OUP)
Identification Number: 10.1093/rheumatology/keac388
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)